GTx, Inc. (GTXI) financial statements (2021 and earlier)

Company profile

Business Address 12230 EL CAMINO REAL
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments20284422294915
Cash and cash equivalents2028169141815
Short-term investments 0281315310
Other undisclosed current assets1322310
Total current assets:21314624325015
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment 000000
Intangible assets, net (including goodwill) 000  
Intangible assets, net (excluding goodwill) 000   
Other noncurrent assets1      
Other undisclosed noncurrent assets    000
Total noncurrent assets:1000010
TOTAL ASSETS:22314625325116
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4331012
Accounts payable1331011
Accrued liabilities3      
Employee-related liabilities 000001
Debt0      
Deferred tax liabilities    00
Other undisclosed current liabilities425330322
Total current liabilities:758530335
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Liabilities, other than long-term debt     00
Other liabilities     00
Total noncurrent liabilities:0    00
Total liabilities:758530335
Stockholders' equity
Stockholders' equity attributable to parent1426382021811
Common stock0000000
Additional paid in capital80626600551515512466
Accumulated deficit(66)(600)(562)(531)(513)(495)(455)
Total stockholders' equity:1426382021811
TOTAL LIABILITIES AND EQUITY:22314625325116

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Gross profit:2      
Operating expenses(36)(39)(31)(26)(22)(30)(44)
Operating loss:(33)(39)(31)(26)(22)(30)(44)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(1)1000(0)1
Loss from continuing operations before equity method investments, income taxes:(34)(38)(30)(26)(22)(31)(42)
Other undisclosed loss from continuing operations before income taxes     (9) 
Net loss:(34)(38)(30)(26)(22)(39)(42)
Other undisclosed net income attributable to parent   83  
Net loss available to common stockholders, basic:(34)(38)(30)(18)(19)(39)(42)
Other undisclosed net loss available to common stockholders, diluted    (3)  
Net loss available to common stockholders, diluted:(34)(38)(30)(18)(22)(39)(42)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(34)(38)(30)(26)(22)(39)(42)
Comprehensive loss, net of tax, attributable to parent:(34)(38)(30)(26)(22)(39)(42)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: